Testing effectiveness (Phase 2)Study completedNCT02189772
What this trial is testing
Safety and Tolerability Study of Metadoxine Extended Release (MDX) (Previously Known as MG01CI) in PI-ADHD Adolescent Subjects
Who this might be right for
ADHD, Predominantly Inattentive Type
Alcobra Ltd. 83